APA (7th ed.) Citation

Reardon, D. A., Galanis, E., DeGroot, J. F., Cloughesy, T. F., Wefel, J. S., Lamborn, K. R., . . . Wen, P. Y. (2011). Clinical trial end points for high-grade glioma: The evolving landscape. Neuro-Oncology, 13(3), . https://doi.org/10.1093/neuonc/noq203

Chicago Style (17th ed.) Citation

Reardon, David A., et al. "Clinical Trial End Points for High-grade Glioma: The Evolving Landscape." Neuro-Oncology 13, no. 3 (2011). https://doi.org/10.1093/neuonc/noq203.

MLA (9th ed.) Citation

Reardon, David A., et al. "Clinical Trial End Points for High-grade Glioma: The Evolving Landscape." Neuro-Oncology, vol. 13, no. 3, 2011, https://doi.org/10.1093/neuonc/noq203.